Table II.
Association between CENPU expression and clinicopathological characteristics of the bladder cancer cases (n=100).
| CENPU expression | ||||
|---|---|---|---|---|
| Variables | Total no. n (%) | Low n (%) | High n (%) | P-value |
| Sex | ||||
| Male | 58 (58.0) | 17 (51.5) | 41 (61.2) | 0.356 |
| Female | 42 (42.0) | 16 (48.5) | 26 (38.8) | |
| Age (years) | ||||
| ≤60 | 34 (34.0) | 13 (39.4) | 21 (31.3) | 0.424 |
| >60 | 66 (66.0) | 20 (60.6) | 46 (68.7) | |
| Tumor size (cm) | ||||
| ≤3 | 29 (29.0) | 5 (15.2) | 24 (35.8) | 0.032 |
| >3 | 71 (71.0) | 28 (84.8) | 43 (64.2) | |
| Histological grade | ||||
| Urothelial | 61 (61.0) | 23 (69.7) | 38 (56.7) | 0.211 |
| Other | 39 (39.0) | 10 (30.3) | 29 (43.3) | |
| TNM stage | ||||
| 0/I | 18 (18.0) | 2 (93.9) | 16 (23.9) | 0.029 |
| II/III | 82 (82.0) | 31 (6.1) | 51 (76.1) | |